Mitigating Fraud and Abuse Risks With the CARES Act Provider Relief Fund

With deep experience both in government and the private sector, Mr. Davis is an accomplished litigator who focuses on government investigations, compliance counseling and complex litigation. Until September 2020, he served as the Acting Assistant Attorney General for the U.S. Department of Justice’s Civil Division, the Department’s largest litigating division, where he oversaw about 1,000 lawyers. In that role, Mr. Davis supervised the DOJ’s investigations and litigation under the False Claims Act, and played a key role in laying the groundwork to combat fraud in the CARES Act’s stimulus programs. Prior to his government service, he was a litigation partner with the firm, where he helped companies in the life sciences, healthcare, technology, and energy sectors navigate government investigations and represented them in complex, high-stakes commercial and government-facing litigation.

Mr. Urbanowicz is Co-Head of the firm’s Healthcare Industry Group. An experienced corporate officer, board member, presidential appointee, restructuring consultant and attorney, he has built and led highly functioning management teams and improved the financial performance and operations of leading healthcare organizations. Mr. Urbanowicz’s public service background assists healthcare and life sciences companies in navigating a complex and challenging regulatory, market and political environment. He is a former Chief of Staff to Alex Azar II, the Secretary of the Department of Health and Human Services. As HHS Chief of Staff, Mr. Urbanowicz functioned as the department’s chief operating officer and was responsible for coordinating all of HHS’ agencies and staff divisions. He was publicly credited for his vital role in the agency’s work to lower prescription drug prices, advance value-based care, and improve rural healthcare access. Mr. Urbanowicz also served as Principal Deputy General Counsel at HHS during the administration of President George W. Bush where he was part of the team that drafted the historic legislation creating the Medicare Part D drug program and Medicare Advantage plans.

Mr. Zall advises healthcare companies, investors and lenders in their most challenging transactions, including M&As, joint ventures, financings and complex commercial agreements. He advises clients on state and federal healthcare regulatory compliance matters, including the corporate practice of medicine, digital health, telemedicine, HIPAA, fraud and abuse, Medicare and Medicaid payment reimbursement, MACRA, and value based payment. Mr. Zall is a respected thought leader in the healthcare industry and frequently presents at key industry events.